- Infection prevention and control in the context of coronavirus disease … – World Health Organization: The Infection Prevention and Control in the context of Coronavirus Disease 2019 (COVID-19) guidelines provide evidence-informed recommendations for IPC, including a strong recommendation for mask use in community settings in higher risk situations, a conditional recommendation to encourage a risk-based approach for mask use in community settings in other situations, and a good practice statement advising individuals to practice hand hygiene and physical distancing.
- Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization: The WHO Therapeutics and COVID-19: Living Guideline contains the most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. It is available in pdf format and online, and is updated regularly. The WHO Living Guideline: Drugs to Prevent COVID-19 is a separate document that can be accessed online or in pdf format. It contains guidelines regarding the use of drugs to prevent COVID-19.
- Clinical management of COVID-19: Living guideline, 13 January 2023 – World Health Organization: The 6th version of the COVID-19 care pathway includes new conditional recommendations for ten days of isolation for symptomatic individuals and five days of isolation for asymptomatic individuals, as well as the use of rapid-antigen testing to reduce the period of isolation.
- Machine learning identifies long COVID patterns from electronic … – Nature.com: This article by Al-Aly, Xie, and Bowe provides a systematic characterization of post-acute sequelae of COVID-19. Yan and Al-Aly’s subsequent article describes the range of cardiovascular disorders in the post-acute phase of SARS-CoV-2 infection, and their third article examines the increased risk of diabetes in long COVID.
- Long COVID symptoms may ease within a year: research – The Hill: Israeli researchers have recently completed a study indicating that Long COVID, a condition with persisting symptoms following a COVID-19 infection, may resolve relatively quickly. The study looked at the health outcomes of nearly 2 million mild COVID-19 cases, including both vaccinated and unvaccinated individuals, and found common health conditions associated with the virus such as loss of smell, breathing issues, and impacts on concentration.
- Most ‘long COVID’ symptoms after mild case of virus resolve in about a year: new study – Fox News: A new study out of Israel has found that most people with “long COVID” following a mild case of the COVID-19 virus have their symptoms resolve after a year. The study examined 1,913,234 patient records from the Israeli HMO Maccabi Healthcare Services and found that about 300,000 of those patients tested positive for the virus. The study also found that the number of cases of COVID-Omicron Subvariant XBB is likely far greater than reported due to its mild symptoms.
- Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster … – CDC: This report adds early safety findings from v-safe and the Vaccine Adverse Event Reporting System (VAERS) for bivalent booster vaccination in children aged 5–11 years, which are similar to those described for monovalent vaccines.
- Dr. Lyne Filiatrault: It’s time to reinstate a mask mandate in B.C. schools – The Province: B.C. is facing a perfect storm of respiratory viruses that is overwhelming children’s hospitals and pediatric ICUs, causing trauma and devastation for many families. In light of this, B.C. public health should be doing more to lessen the impact of these viruses on children, educators, and their families, such as by implementing measures in schools to reduce COVID transmission.
- Woman struggling after COVID diagnosis receives help – WREG NewsChannel 3: Karen Jones, a South Memphis woman, was diagnosed with COVID-19 last year and has been struggling since. News Channel 3 and anonymous donors have provided her with assistance this week. She has two children with disabilities and is going through a disability case.
- San Francisco Braces for ‘Kraken’ Covid Variant Now Dominating … – The San Francisco Standard: Dr. Rasu Shrestha, executive vice president of Advocate Health, wore a mask to the J.P. Morgan Healthcare Conference in Union Square as a Covid precaution, noting that only 5% of people were doing the same. He expressed concern about the XBB.1.5 strain of Covid, which is more contagious than previous strains, and the low rate of adoption of the second booster vaccine.
- Do Coloradans need to care about the new COVID variant, XBB? – The Colorado Sun: Yes, XBB.1.5 is a concerning variant of SARS-CoV-2 and it is important to take precautions to protect yourself and others from it.
Daily News Pulse for April 05, 2023
April 5, 2023
Summary: The domestic box office is close to reaching pre-pandemic levels, with mid-budget films helping to bring moviegoers back. Research has found that diabetes is a major factor in the severity of COVID-19 cases. The US government is planning to authorize booster doses of the vaccine for high-risk populations.
